Skip to content
OpenCapital
Get started

XTI Aerospace, Inc. XTIA Other Research And Development Expense

Other Research And Development Expense at other companies

OS Therapies logo
OS TherapiesOSTX
$0—
CTO
Citius Oncology, Inc.CTOR
$469K-2.3%
Celanese Corporation logo
Celanese CorporationCE
$0—
Corvex logo
Corvex MOVE
$899K+12.4%
RFL
Rafael Holdings, Inc.RFL
$22K-51.1%
Comstock Inc. logo
Comstock Inc.LODE
$0-100%

Segments

By segment

See full
ADS$1.15M—
UAS$48K—

Other financials

Income statement

See full
Revenue$27.7M+5,622%
Gross profit$5.1M+1,436%
Operating income-$10.4M-26.7%
Net income-$35.3M-174%
EPS (diluted)-$1.00+73.7%

Balance sheet

See full
Cash & equivalents$15.2M+89.6%
Total debt$22.8M+14,541%
Total equity-$26.6M-291%
Total assets$78.3M+189%

Cash flow

See full
Operating cash flow-$10.5M+31.4%
CapEx$131.0K+191%
Free cash flow-$10.6M+30.8%

Valuation

See full
Market cap$69.64M+136%
Enterprise value$77.3M+970%
P/S1.4×-8.3×

Profitability

See full
Gross margin19.6%-40.5pp
Operating margin-86.1%-40.7pp
Net margin-183.4%-84.9pp
FCF margin-64.6%-31.3pp

Returns & leverage

See full
Return on equity-565.7%—
Debt / equity1.1×+0.6×
Current ratio0.6×-0.4×